# SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

> **NCT02870153** · PHASE2 · UNKNOWN · sponsor: **The First People's Hospital of Changzhou** · enrollment: 60 (estimated)

## Conditions studied

- Colorectal Neoplasm

## Interventions

- **DRUG:** SOX
- **DRUG:** XELOX

## Key facts

- **NCT ID:** NCT02870153
- **Lead sponsor:** The First People's Hospital of Changzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02870153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02870153, "SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02870153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*